Fed. Circ. Affirms PTAB Save Of Merck Diabetes Drug Patent
The Federal Circuit has backed the Patent Trial and Appeal Board's decision to uphold a patent on Merck's blockbuster diabetes drug Januvia, the latest decision in a broader fight between Merck...To view the full article, register now.
Already a subscriber? Click here to view full article